TransCode Therapeutics, Inc.
$28.8 M
IPO
Sole Book-Runner
OMNIQ Corp.
$15 M
Private Placement
Sole Placement Agent
Kiromic BioPharma, Inc.
$40 M
Follow-On Offering
Sole Book-Runner
cbdMD, Inc.
$16.5 M
8% Series A Cumulative Convertible Preferred Stock
Sole Book-Runner
Second Sight Medical Products, Inc.
$57.5 M
Follow-On Offering
Sole Book-Runner
FAT Brands Inc.
$9.2 M
8.25% Series B Cumulative Preferred Stock
Sole Book-Runner
iSpecimen Inc.
$20.7 M
IPO
Sole Book-Runner
Inhibikase Therapeutics, Inc.
$45 M
Follow-On Offering
Sole Book-Runner
Harbor Custom Development, Inc.
$31.5 M
8% Series A Cumulative Convertible Preferred Stock
Sole Book-Runner
BK Technologies Corporation
$12.8 M
Follow-On Offering
Sole Book-Runner
Altamira Therapeutics Ltd.
M&A
Advisor
BriaCell Therapeutics Corp.
$27.2 M
Private Placement
Sole Placement Agent